Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion Gets OK from Creditors for Reorganization Plan

NEW YORK (GenomeWeb News) – Vermillion today said that its unsecured creditors have "overwhelmingly accepted" its First Amended Chapter 11 Plan of Reorganization.

Approval of the plan clears the way for the Fremont, Calif.-based molecular diagnostics firm to proceed to a confirmation hearing for the plan before the US Bankruptcy Court for the District of Delaware. That confirmation hearing is scheduled for tomorrow, Jan. 7.

Vermillion filed for Chapter 11 bankruptcy protection on March 30, 2009, but stayed in business as it sought US Food and Drug Administration clearance for its OVA1 ovarian tumor triage diagnostic test, which the firm received in September.

The firm subsequently filed its plan of reorganization and disclosure statement with the US Bankruptcy Court in November.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.